Clinical Strategies for Severe Asthma and Chronic Inflammatory Airway Diseases
This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.
Overview:
Activity Release Date: November 27, 2024
Activity Expiration Date: November 27, 2025
Estimated time to complete Activity: 75 minutes
Provider Statement
This activity is provided by National Jewish Health.
Support Statement
This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals.
Target Audience
Pulmonologists, Allergists, and Nurse Practitioners and Physician Assistants in those specialties who care for patients with asthma and chronic inflammatory airway diseases.
Program Description
Recent studies have uncovered the staggering prevalence of asthma in patients suffering from upper airway disorders. The inflammation in upper airways can intensify inflammatory responses in the lower airways, causing a vicious cycle of symptoms and exacerbations.
This educational program will bring together expert pulmonologists and allergists to discuss the complex and interconnected relationship between severe asthma and upper airway disease, including inflammatory pathways and biomarkers in chronic respiratory disease, current and emerging therapies for managing patients with severe asthma and comorbid upper airway disease. Participants can choose from four case scenarios that illustrate strategies for personalizing treatment plans for complex patients.
Learning Objectives
- Identify the features in the pathophysiology of upper and lower airways associated with chronic inflammatory airway diseases
- Analyze the role of epithelial cytokines in the inflammatory pathways in severe asthma and upper airway diseases
- Describe appropriate biomarkers for severe asthma and upper airway diseases
- Assess the impact of upper airway diseases in order to personalize treatment strategies for severe asthma
Faculty
Ronald Balkissoon, MD, MSc, DIH, FRCPC
Staff Physician
Division of Pulmonary, Critical Care & Sleep Medicine
Department of Medicine
National Jewish Health
Denver, Colorado
David Beuther, MD, PhD, FCCP
Chief Medical Information Officer
Professor of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, Colorado
Eileen Wang, MD, MPH
Associate Professor
Division of Allergy & Clinical Immunology
Department of Medicine
National Jewish Health
Denver, Colorado
Accreditation
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
National Jewish Health designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
How to Participate in this Activity and Obtain CME Credit
In order to receive CME credit, participants must complete the pre-assessment, view the activity content, and complete the post-assessment and program evaluation. Participants must get 3 out of 4 answers correct on the post-assessment. A certificate will be distributed via email once the activity is complete.
Conflicts of Interest Disclosure Policy
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), National Jewish Health requires that all program faculty, content developers, reviewers, and others in a position to control the content of this activity disclose to learners the presence or absence of any relevant financial relationships with an ACCME-defined ineligible company within the preceding 24 months of the activity. The ACCME defines an “ineligible company” as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Our goal is to ensure that there is no compromise in the ethical relationship that exists between those in a position to control the content of the activity and those participating in the activity and their respective professional duties. All accredited education activities offered by National Jewish Health are reviewed to ensure a balanced and evidence-based presentation
All relevant financial relationships among individuals in a position to control the content of this activity have been identified and mitigated according to the Standards of Integrity and Independence in Accredited Continuing Education.
Faculty Disclosures
Ronald Balkissoon, MD, MSc, DIH, FRCPC discloses the following relevant financial relationships:
- Advisory Board: AstraZeneca Pharmaceuticals, GlaxoSmithKline, Sanofi, Regeneron
- Consultant: AstraZeneca Pharmaceuticals, GlaxoSmithKline, Sanofi, Regeneron
- Speaker: AstraZeneca Pharmaceuticals, GlaxoSmithKline, Sanofi, Regeneron
David Beuther, MD, PhD, FCCP discloses the following relevant financial relationships:
- Advisory Board: AstraZeneca Pharmaceuticals
- Speaker: AstraZeneca Pharmaceuticals
Eileen Wang, MD, MPH discloses the following relevant financial relationships:
- Advisory Board: AstraZeneca Pharmaceuticals, GlaxoSmithKline
- Consultant: AstraZeneca Pharmaceuticals
- Speaker: AstraZeneca Pharmaceuticals, Genentech
- Investigator for studies funded by: AstraZeneca Pharmaceuticals, Genentech, GlaxoSmithKline and Sanofi
Planner and Reviewer Disclosures
Meghan Brenner, MA does not have any relevant financial relationships to disclose.
Laniecia Demmer does not have any relevant financial relationships to disclose. Andrea Harshman, MHA, CHCP, CMP-HC does not have any relevant financial relationships to disclose. Harold Nelson, MD does not have any relevant financial relationships to discloseUnlabeled and Investigational Usage
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses.
Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.
Disclaimer Statement
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Privacy Policy
The Office of Professional Education of National Jewish Health respects and values your privacy and the confidentiality of the information you choose to share with us. We are committed to protection of this information and will assure your privacy when participating in our Internet Continuing Medical Education (CME). We do not collect any personal information about a visit unless that information is provided voluntarily. We may collect aggregate information on web pages visited in order to assess and improve the content of our Internet CME programming. If you decide to register for an Internet CME program, we will collect personal information that you voluntarily share with us. We will only use this information to notify you of future National Jewish Health CME activities. https://www.nationaljewish.org/education-training/pro-ed/privacy-policy-and-practices
CME Questions?
Contact proed@njhealth.org with any questions about the accreditation of this program.